BET bromodomain inhibitors in leukemia. (2015)
Attributed to:
Characterising and targeting aberrant enhancer function in acute myeloid leukaemia (AML)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.exphem.2015.06.004
PubMed Identifier: 26163798
Publication URI: http://europepmc.org/abstract/MED/26163798
Type: Journal Article/Review
Volume: 43
Parent Publication: Experimental hematology
Issue: 8
ISSN: 0301-472X